PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong Special Administrative Region. Electronic address: jkwlam@hku.hk.\', \'Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong Special Administrative Region; School of Pharmacy, University of Nottingham, University Park, Nottingham, United Kingdom.\', \'Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong Special Administrative Region; Sydney Pharmacy School, Faculty of Medicine and Health, University of Sydney, Australia.\', \'Helen and Douglas House, Oxford University Hospitals NHS Foundation Trust, United Kingdom.\', \'Oxford University Hospitals NHS Foundation Trust, United Kingdom.\', \'Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge, United Kingdom.\', \'Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong Special Administrative Region; Centre for Medicines Optimisation Research and Education (CMORE), Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0169-409X(20)30165-410.1016/j.addr.2020.10.018
?:doi
?:hasPublicationType
?:journal
  • Advanced drug delivery reviews
is ?:pmid of
?:pmid
?:pmid
  • 33137363
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.09
?:rankingScore_hIndex
  • 261
?:title
  • Transmucosal drug administration as an alternative route in palliative and end-of-life care during the COVID-19 pandemic.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all